Drugs With A Difference Limited

Drugs With A Difference Limited repurposes established drugs for use in cancer chemotherapy. As we are repurposing established drugs that are currently used in clinical practice, the path to market is financially more attractive as it costs less, is far quicker and has fewer regulatory hurdles. Drugs With A Difference generates commercially valuable intellectual property (IP) in the form of patents for the drugs we have repurposed for use in human cancer patients for a wide range of solid tumours and leukaemias in adults and children. This IP is then licensed to large international pharmaceutical companies. The team at Drugs With A Difference Limited has broad and deep experience in all aspects of the business of biomedical and drug research and development, and its financial and general management. These areas of expertise include extensive knowledge of research and development in the areas of: Cancer, Pharmacology, Medicinal Chemistry, Biochemistry, Cell Biology, Toxicology, Drug Formulation and Delivery, Intellectual Property and Patenting, Drug Repurposing, Drug Licensing, Contract and Licensing Law, Good Laboratory Practise/ISO standards and MHRA Laboratory Licensing.